Stock Report: Tianyin Pharmaceutical Co. Inc. (TPI) Report Updated: Nov 16, 2009  |  Print This Page

Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China. The company’s products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, and pediatrics. It manufactures a portfolio of 39 modernized traditional Chinese medicines and pharmaceuticals, and has a pipeline of 17 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People’s Republic of China.